Global Smart Labels Market Overview, 2025-30

The global maternal health market is experiencing robust growth driven by evolving cultural perspectives, urbanization, technological innovations, and changing regulatory frameworks. Culturally, there is a rising awareness and demand for comprehensive maternal care that goes beyond physical health to include mental and emotional well-being. This shift is reflected in the booming maternal mental health segment, which is projected to grow at an impressive rate over the next decade. Additionally, consumer preferences are leaning toward organic and natural pregnancy care products, underscoring the demand for safer and holistic maternal wellness solutions. While urban centers generally provide better healthcare infrastructure and access to specialized maternal services, challenges such as overcrowding, pollution, and lifestyle-related complications are increasing the complexity of maternal health needs in these areas. The HHS Secretary’s Postpartum mother Health Collaborative was launched in February 2024 by the U.S. Department of Health and Human Services and other leaders to improve mother and child health in rural communities. Technological innovations are transforming the maternal health landscape, with artificial intelligence (AI) playing a pivotal role in enhancing patient engagement, personalized care, and remote monitoring. For instance, AI-powered tools are being developed for real-time fetal health assessments, especially beneficial in resource-constrained settings, which could disrupt traditional care models by enabling earlier interventions and better health outcomes. International organizations such as the World Health Organization (WHO), United Nations Population Fund (UNFPA), and World Bank have launched initiatives to increase funding for maternal health programs and services in low- and middle-income countries. These initiatives provide resources for maternal health research, training for healthcare workers, and the development of maternal health infrastructure.

According to the research report, ""Global Maternal Health Market Overview, 2030,"" published by Bonafide Research, the Global Maternal Health market was valued at more than USD 25.37 Billion in 2024, with the CAGR of 8.61% from 2025-2030. The global maternal health market is witnessing robust growth fueled by several key factors that are reshaping the landscape of maternal care worldwide. Technological innovations such as AI-powered diagnostic tools, mobile health applications, and telemedicine are significantly enhancing the quality and accessibility of maternal healthcare, especially in remote and underserved regions. For example, organizations like the United Nations Population Fund (UNFPA) have implemented mobile apps to support midwives, improving outcomes in rural areas. Policy initiatives and philanthropic commitments, including a $2.5 billion pledge by the Gates Foundation to advance women’s health by 2030, are driving further momentum by prioritizing maternal health in global health agendas. Mallinckrodt Inc. is a global company that develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. The fourth-quarter 2024 net sales were $492.1 million, compared to $469.3 million in 2023. The net sales of the company in fiscal year 2024 were $1.98 billion, an increase of 6.1% from 2023. Supporting this dynamic market are numerous conferences and seminars such as the Maternal and Child Health Conference 2025 and the International Conference on Midwifery and Nurse Practitioners, which provide vital platforms for healthcare professionals to share innovations, research, and best practices. For instance, only about 1% of healthcare research and development spending targets female-specific conditions beyond cancer, highlighting a significant gap that stakeholders aim to bridge. Moreover, countries like Nigeria have joined global networks dedicated to accelerating maternal health innovations, signaling a growing international commitment. Sage Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes brain health medicines. The company developed the only two FDA-approved treatments for postpartum depression (PPD), including Zurzuvae (zuranolone).

Market Drivers

• Increasing Awareness and Focus on Maternal Health: With growing recognition of the importance of maternal health for both mothers and newborns, governments and international organizations have intensified efforts to improve maternal healthcare services worldwide. Campaigns promoting prenatal care, skilled birth attendance, and postnatal support have raised awareness among women, leading to increased demand for maternal health products and services. This awareness drives market growth as more women seek quality healthcare interventions, including diagnostics, supplements, and advanced medical devices, to ensure safe pregnancies and deliveries.
• Rising Prevalence of Pregnancy-Related Complications: The increase in high-risk pregnancies due to factors such as advanced maternal age, lifestyle diseases (e.g., diabetes, hypertension), and multiple births has heightened the need for specialized maternal healthcare solutions. This has propelled demand for sophisticated monitoring devices, diagnostic tools, and treatment options to manage complications like preeclampsia, gestational diabetes, and premature labor. Healthcare providers and manufacturers are thus innovating and expanding their offerings, fueling market expansion globally.

Market Challenges

• Limited Healthcare Infrastructure in Low-Resource Settings: In many developing countries, inadequate healthcare infrastructure, including shortage of skilled healthcare professionals and lack of access to quality medical facilities, significantly hampers maternal health outcomes. These limitations restrict market penetration and the delivery of advanced maternal health solutions, especially in rural or underserved regions. Addressing these infrastructural challenges remains a critical barrier for market growth and calls for targeted investments and public-private partnerships.
• High Cost of Advanced Maternal Health Technologies: Cutting-edge maternal health devices and treatments often come with a high price tag, making them less accessible in low- and middle-income countries where the need is often greatest. The cost barrier limits adoption and widespread use of advanced diagnostics and therapeutics, slowing market growth. Moreover, reimbursement issues and affordability concerns persist even in developed markets, affecting how quickly new innovations reach end-users.

Market Trends

• Adoption of Digital Health and Telemedicine in Maternal Care: Digital health technologies, including mobile health apps, remote monitoring devices, and telemedicine platforms, are transforming maternal healthcare by improving access and enabling continuous monitoring. These technologies help bridge the gap between patients and providers, especially in remote or resource-poor areas, facilitating timely interventions and personalized care. The growing trend of integrating AI and data analytics in maternal health is expected to enhance predictive diagnostics and outcomes.
• Emphasis on Personalized and Preventive Maternal Healthcare: There is a growing shift toward personalized medicine and preventive approaches in maternal health. This includes tailored nutrition, risk assessment based on genetic and lifestyle factors, and early intervention strategies to prevent complications. The market is witnessing increased development of customized supplements, wearable devices, and screening tests aimed at improving maternal and fetal health outcomes. This trend aligns with the broader global focus on patient-centered care models and improved quality of life.

The rising incidence of ectopic pregnancy in the global maternal health industry is primarily driven by increasing prevalence of risk factors such as pelvic inflammatory disease (PID), assisted reproductive technologies (ART), and delayed childbearing.

Ectopic pregnancy, a condition where a fertilized egg implants outside the uterine cavity—most commonly in the fallopian tubes is witnessing a noticeable rise globally, which is significantly impacting the maternal health landscape. This increase is closely linked to the growing prevalence of key risk factors that predispose women to this potentially life-threatening condition. Pelvic inflammatory disease (PID), often caused by sexually transmitted infections such as chlamydia and gonorrhea, leads to scarring and damage in the fallopian tubes, impeding the normal passage of the fertilized egg to the uterus. This damage creates an environment conducive for ectopic implantation. The global burden of PID has escalated in recent years due to higher rates of unsafe sexual practices and limited access to early diagnosis and treatment, especially in low- and middle-income countries, thereby contributing to the rising ectopic pregnancy cases. ART procedures, while offering hope to many infertile couples, can increase the likelihood of abnormal embryo implantation due to factors like embryo transfer techniques or underlying tubal damage in patients undergoing these treatments. Moreover, the trend of delayed childbearing observed worldwide, particularly in developed regions, also plays a critical role. Women who conceive at older ages often have a higher risk of reproductive tract abnormalities, including tubal damage from previous infections or surgeries, which escalates the chance of ectopic implantation. This delay in pregnancy also coincides with higher rates of comorbidities such as endometriosis or previous pelvic surgeries, further increasing vulnerability.

Gestational Diabetes Mellitus (GDM) is the largest complication type in the global maternal health industry primarily due to its high prevalence linked to widespread risk factors like obesity, advanced maternal age.

Gestational Diabetes Mellitus (GDM) has emerged as the largest and one of the most significant maternal health complications globally, largely because it affects a substantial proportion of pregnant women and carries serious short- and long-term health implications for both mother and child. The high prevalence of GDM is closely associated with the increasing global burden of risk factors such as obesity and overweight, which have become endemic in both developed and developing countries. Excess body fat disrupts normal insulin function and increases insulin resistance, creating an environment where glucose regulation during pregnancy becomes impaired. This metabolic challenge is further exacerbated by modern sedentary lifestyles, poor nutrition, and rising rates of metabolic syndrome, making more women vulnerable to developing GDM during pregnancy. Additionally, the trend of delayed childbearing, with women increasingly conceiving at older ages, contributes significantly to the size of this complication group, as advanced maternal age is a well-established risk factor for impaired glucose tolerance and GDM. Many countries have adopted universal or risk-based screening guidelines that detect even mild forms of gestational diabetes, resulting in a larger diagnosed population. This increased detection, while beneficial for early management, has highlighted the extensive scale of GDM’s impact. Furthermore, GDM is linked to several serious pregnancy complications, including preeclampsia, preterm birth, and increased rates of cesarean delivery, which adds to the healthcare burden. Long-term, women with GDM are at heightened risk of developing type 2 diabetes later in life, and their offspring also face increased susceptibility to obesity and metabolic diseases, indicating a multigenerational health impact.

The rise in Caesarean section (C-section) deliveries globally is mainly driven by increasing maternal age, higher prevalence of pregnancy complications, and evolving clinical practices favoring surgical intervention for safer birth outcomes.

Caesarean section delivery has been steadily increasing worldwide, becoming a significant trend in the global maternal health industry. This growth is primarily fueled by several intertwined factors, starting with the demographic shift toward older maternal age at childbirth. As more women delay pregnancy for personal, professional, or health reasons, the likelihood of complications such as fetal distress, preeclampsia, or labor dystocia rises, prompting healthcare providers to opt for C-sections as a safer alternative to vaginal delivery. Older maternal age is associated with a higher risk of chronic conditions such as hypertension and diabetes, which further complicate pregnancies and often necessitate surgical intervention. Women with a history of prior C-sections are often recommended to undergo repeat surgical delivery to reduce the risk of uterine rupture, which has contributed significantly to the rising numbers. Additionally, advances in prenatal diagnostics have led to earlier detection of fetal and maternal risks, prompting more precautionary C-sections to ensure the safety of both mother and baby. Evolving clinical guidelines and medico-legal concerns have also influenced this trend. In many healthcare systems, practitioners may favor C-sections to avoid potential complications and associated litigation, especially in environments where patient safety and outcome assurance are paramount. Moreover, patient preference and socio-cultural factors play a role; some expectant mothers opt for scheduled C-sections to avoid labor pain, coordinate delivery timing, or due to perceptions of enhanced safety.

The growth of Maternity & Specialty Clinics as an application type in the global maternal health industry is primarily driven by increasing demand for specialized, comprehensive prenatal and postnatal care amid rising maternal health complexities.

Maternity & Specialty Clinics have become one of the fastest-growing application types within the global maternal health industry, reflecting broader shifts in healthcare delivery that emphasize specialized, patient-centered care. This growth is mainly propelled by the increasing complexity of maternal health needs due to a rise in high-risk pregnancies, chronic conditions in expectant mothers, and growing awareness about the importance of dedicated prenatal and postnatal care. As more women enter pregnancy at advanced ages or with preexisting conditions like diabetes, hypertension, or obesity, there is a heightened need for specialized monitoring and interventions that general healthcare facilities may not be fully equipped to provide. Maternity & Specialty Clinics offer focused expertise and advanced diagnostic tools tailored specifically for maternal and fetal health, ensuring better management of complications such as gestational diabetes, preeclampsia, and fetal growth restrictions. Additionally, growing patient awareness and demand for personalized healthcare solutions have played a significant role in driving the expansion of these clinics. Women today seek not only clinical care but also comprehensive support services including counseling, nutrition guidance, and childbirth education that enhance overall pregnancy outcomes and maternal well-being. Specialty clinics often provide a multidisciplinary approach, integrating obstetricians, neonatologists, nutritionists, and mental health professionals, which makes them highly attractive to expectant mothers wanting holistic care.

The growth of postnatal care in the global maternal health industry is primarily driven by increased recognition of the critical importance of maternal and newborn health during the postpartum period and rising efforts to reduce maternal and infant mortality and morbidity.

Postnatal care is gaining significant traction worldwide as an essential component of maternal health, reflecting a growing awareness of the unique health challenges faced by mothers and newborns after childbirth. Traditionally, maternal health efforts focused predominantly on prenatal care and safe delivery; however, the postpartum period is increasingly recognized as a vulnerable phase where complications such as infections, postpartum hemorrhage, mental health disorders, and neonatal health issues can arise. The rising emphasis on comprehensive maternal care that spans pregnancy through the postnatal period has propelled the demand for structured, high-quality postnatal services. Healthcare providers and policymakers now understand that effective postnatal care is critical for detecting and managing complications early, supporting breastfeeding and infant nutrition, monitoring physical and mental recovery of the mother, and fostering long-term health for both mother and child. Global health initiatives and guidelines from organizations such as WHO have emphasized strengthening postnatal care frameworks, encouraging countries to implement standardized check-ups within the first six weeks after delivery. This shift has led to increased government and private sector investments in postnatal programs, infrastructure, and awareness campaigns. Moreover, the increase in institutional deliveries and improved healthcare access globally ensures more mothers are reachable for postnatal follow-ups, contributing to the expansion of this care type. The rise in maternal mental health awareness, including postpartum depression and anxiety, has also underscored the importance of postnatal care services that extend beyond physical health to encompass psychological well-being.

The Middle East and Africa (MEA) region is growing in the global maternal health industry primarily due to increasing government initiatives, rising awareness about maternal health, and improving healthcare infrastructure driven by demographic changes and urbanization.

The growth of the maternal health industry in the MEA region can be attributed to a convergence of several key factors that are shaping the demand and supply dynamics. Firstly, many countries in this region are experiencing significant demographic shifts, including high birth rates and a youthful population, which naturally increases the demand for maternal healthcare services. Governments across the MEA region have recognized the urgent need to reduce maternal mortality rates and improve maternal health outcomes, which has led to the launch of various national health programs, policy reforms, and increased budget allocation toward maternal and child health. These initiatives often include expanding access to prenatal and postnatal care, improving emergency obstetric services, and increasing the availability of skilled birth attendants. Additionally, urbanization in MEA countries has led to better healthcare access for large segments of the population as cities tend to have more advanced medical facilities, leading to a rise in institutional deliveries and better maternal health monitoring. Awareness campaigns and education efforts aimed at informing women about the importance of regular check-ups, nutrition, and early detection of complications are also playing a vital role in driving demand. This rise in awareness is bolstered by partnerships between governments, NGOs, and international organizations focusing on maternal health education and services. Furthermore, technological advancements and increasing penetration of digital health solutions, such as telemedicine and mobile health platforms, are helping overcome geographic and socio-economic barriers to healthcare access, especially in remote and underserved areas.

• In March 2025, in the midst of growing uncertainty over international research funding, a new global health research program was just established that uses music to help pregnant women's mental health. CHIME is a significant investment in maternal mental health research in the Global South, having been funded with over £2.8 million (around US$3.5 million) by the UK's National Institute for Health and Care Research (NIHR).
• In January 2025, HRSA commemorated a historic year of strengthening maternal health programs by announcing increased funding, policy action, and reports. $9 million in additional funds to maintain and expand the state of the Enhancing Maternal Health Initiative.
• In October 2024, 15 states will receive awards totaling about $19 million from the U.S. Department of Health and Human Services (HHS)'s Health Resources and Services Administration (HRSA) to develop and put into practice creative solutions to the maternal health issue.
• In April 2024, LunaJoy Health announced the introduction of LunaCare, a revolutionary integrated care program designed to enhance mother mental health outcomes and reduce inequities in maternal health care. strengthened by fresh investment of $4.2 million.
• In March 2024, Arrowhead Regional Medical Center (ARMC) was listed as a “Birthing-Friendly” hospital for its commitment to providing evidence-based, high-quality maternity care to women and their families in the Inland Empire.
• In February 2023, Biogen Inc. and Sage Therapeutics, Inc. announced that the US Food & Drug Administration has accepted zuranolone's New Drug Application for treating PPD and major depressive disorder. The claim has been granted priority review, and the FDA has assigned an August 5, 2023, Prescription Drug User Fee Act action date.
• In May 2022, Mirvie raised a total of USD 90 million following the closing of its series B funding. The funding encouraged Mirvie’s continued clinical and commercial development of the proprietary Mirvie RNA platform, which is the first to predict preeclampsia and preterm birth months before they happen by revealing the underlying biology of each pregnancy.


***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation. Show more